Loading clinical trials...
Loading clinical trials...
LMWH Versus UFH as ECMO Anticoagulation in Lung Transplantation: A Prospective, Observational, and Pilot Study
Conditions
Locations
1
Czechia
University Hospital Motol, 2nd Faculty of Medicine, Charles University in Prague and 3rd Department of Surgery, First Faculty of Medicine, Charles University, and Motol University Hospital, Lung Transplant Program
Prague, Czech Republic, Czechia
Start Date
May 1, 2025
Primary Completion Date
December 31, 2025
Completion Date
December 31, 2025
Last Updated
June 10, 2025
NCT05837663
NCT07291258
NCT07183605
NCT00552357
NCT06018766
NCT06603350
Lead Sponsor
University Hospital, Motol
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions